Lung Innate Immunity and Microbiome After Tuberculosis Exposure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lung Innate Immunity and Microbiome After Tuberculosis Exposure — Stella

Recruiting

Back to Tuberculosis trials

Trial locations(3 sites)

United Kingdom

Churchill Hospital, Oxford, Oxfordshire

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon

Grove Building, Royal Free NHS Foundation Trust, London

Key details

Sponsor

University of Oxford

Collaborators

University College, London

Enrollment target

~50 participants

Started

August 2024

Primary completion

October 2026

Age range

18 Years – 65 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov